ACS |
Acute coronary syndrome |
AEs |
Adverse events |
BCG |
Bacille Calmette-Guérin |
CCDR |
Canada Communicable Disease Report |
CHMP |
Committee for Medical Products for Human Use |
CI |
Confidence interval |
CVA |
cerebrovascular accident |
DB |
double blind |
EMEA |
European Medicines Evaluation Agency |
GBS |
Guillain-Barré syndrome |
GMT |
Geometric mean titre |
GMR |
geometric mean titre ratio |
HA |
Haemagglutinin antigen |
HI |
Haemagglutination inhibition |
ID |
Intradermal |
ITT |
intention-to-treat |
IgE |
Immune globulin E |
IM |
Intramuscular |
MFI |
mean-fold increase |
mL |
Millilitres |
mm |
Millimitre |
MN |
microneutralization |
NACI |
National Advisory Committee on Immunization |
NS |
not significant |
NT |
neutralization |
ORS |
Oculorespiratory syndrome |
pH1N1 |
Pandemic H1N1 |
RCT |
randomized controlled trial |
SRH |
Single radial haemolysis |
TIV |
Trivalent inactivated influenza vaccine |
TIV-ID |
Trivalent inactivated influenza vaccine administered by the intradermal route |
µg |
Microgram |
WHO |
World Health Organization |